Ireland - English - HPRA (Health Products Regulatory Authority)

laboratorios hipra s.a. - infectious bovine rhinotracheitis virus strain la inactivated, parainfluenza-3 virus strain sf4 inactivated, bovine diarrhoea virus strain nadl inactivated, live bovine respiratory syncitial virus strain lym-56 - pdr+solv for susp for inj - per cent - live and inactivated viral vaccines - bovine - immunological - mixed vaccine (live and inactivated)

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

rural chemical industries (aust) pty ltd - infectious bronchitis virus (poultry) - parenteral liquid/solution/suspension - infectious bronchitis virus (poultry) vaccine-viral active 0.0 p - immunotherapy - poultry - see label | chicken - infectious bronchitis | vaccine | equine rotavirus | infectious bronchitis nephriti

Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - rotavirus g1 reassortant; rotavirus g2 reassortant; rotavirus g3 reassortant; rotavirus g4 reassortant; rotavirus p1a[8] reassortant - oral solution - rotavirus p1a[8] reassortant 2.3 x10 ^6 iu/dose; rotavirus g2 reassortant 2.8 x10 ^6 iu/dose; rotavirus g4 reassortant 2.0 x10^ 6 iu/dose; rotavirus g3 reassortant 2.2 x10 ^6 iu/dose; rotavirus g1 reassortant 2.2 x10 ^6 iu/dose - rota virus diarrhea vaccines - rotateq is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by types g1, g2, g3, g4, and g9 when administered as a 3-dose series to infants between the ages of 6 to 32 weeks. the first dose of rotateq should be administered between 6 and 12 weeks of age

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - bovine herpes virus type 1 strain difivac - suspension for injection - unknown - bovine rhinotracheitis virus vaccine (ibr) - bovine - immunological - inactivated vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - bovine herpes virus type 1 strain difivac - suspension for injection - bovine rhinotracheitis virus (ibr) - bovine - immunological - inactivated vaccine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - inactivated bovine herpes virus type 1.2b - misc. vaccines or anti sera - inactivated bovine herpes virus type 1.2b vaccine-viral active 0.0 orgs/ml - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - bovine respiratory disease | infectious bovine rhinotracheitis (ibr) | shipping fever

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - infectious bursal disease virus (ibd) strain v877 - misc. vaccines or anti sera - infectious bursal disease virus (ibd) strain v877 vaccine-viral active 0.0 p - immunotherapy - fowl - infectious bursal disease | vaccine | bursal disease | equine rotavirus

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis belgium s.a. - bovine herpes virus type 1 (bhv-1), strain difivac - suspension for injection - . - bovine rhinotracheitis virus (ibr) - cattle - immunological - inactivated vaccine

Uganda - English - National Drug Authority

hester biosciences ltd - infectious bursal disease (standard type 1 strain); newcastle disease (lasota strain) and avian infectious bronchitis (mass type strain) - parenteral ordinary vials - infectious bursal disease virus - ?10??²tcid??/dose; new castle disease virus - ?10?eid??/dose and avain infectious brochitis

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - rotavirus g2 human-bovine reassortant, quantity: 1400000 infectious unit/ml; rotavirus g3 human-bovine reassortant, quantity: 1100000 infectious unit/ml; rotavirus g1 human-bovine reassortant, quantity: 1100000 infectious unit/ml; rotavirus g4 human-bovine reassortant, quantity: 1000000 infectious unit/ml; rotavirus p1 [8] human-bovine reassortant, quantity: 1150000 infectious unit/ml - oral liquid - excipient ingredients: polysorbate 80; sucrose; sodium citrate dihydrate; sodium hydroxide; monobasic sodium phosphate; glucose monohydrate; sodium ascorbate; sodium chloride; ammonium metavanadate; calcium chloride dihydrate; cupric sulfate pentahydrate; ferric nitrate nonahydrate; ferrous sulfate heptahydrate; magnesium chloride hexahydrate; dried magnesium sulfate; manganese sulfate tetrahydrate; ammonium molybdate; potassium chloride; sodium acetate; sodium bicarbonate; dibasic sodium phosphate; zinc sulfate heptahydrate; alanine; arginine hydrochloride; asparagine; aspartic acid; cysteine hydrochloride; cystine dihydrochloride; glutamic acid; glycine; histidine hydrochloride monohydrate; hydroxyproline; isoleucine; leucine; lysine hydrochloride; methionine; phenylalanine; proline; serine; threonine; tryptophan; tyrosine disodium; valine; biotin; ergocalciferol; choline chloride; folic acid; inositol; menadione; nicotinamide; nicotinic acid; aminobenzoic acid; calcium pantothenate; pyridoxal hydrochloride; pyridoxine hydrochloride; retinol acetate; riboflavine; dl-alpha-tocopheryl phosphate disodium; thiamine hydrochloride; cyanocobalamin; adenine sulfate dihydrate; adenosine triphosphate disodium; adenosine monophosphate; cholesterol; deoxyribose; glutathione; guanine hydrochloride; sodium hypoxanthine; linoleic acid; alpha lipoic acid; phenolsulfonphthalein; putrescine dihydrochloride; sodium pyruvate; ribose; thymidine; thymine; uracil; sodium xanthine; monoethanolamine; 2-mercaptoethanol; adenosine; uridine; cytidine; guanosine; dexamethasone; epidermal growth factor; hydrocortisone; insulin; alprostadil; liothyronine; ascorbic acid; magnesium sulfate heptahydrate; monobasic sodium phosphate monohydrate; zinc sulfate; arginine; cysteine; cystine; histidine; lysine; tyrosine; adenosine triphosphate; guanine; putrescine - rotateq is indicated for the prevention of rotavirus gastroenteritis (see clinical trials).